乾燥粉末吸入器の世界市場レポート 2025年

乾燥粉末吸入器の市場規模は、今後数年間で安定した成長が見込まれます。2029年にはCAGR5.0％で271億3,000万米ドルに成長します。予測期間の成長は、持続可能性の継続的重視、世界の都市化動向、製造プロセスの進歩、政府の奨励策や政策、世界の経済要因に起因すると考えられます。予測期間における主な動向としては、研究開発の増加、伝統的な建築技術への関心の再燃、材料技術の進歩、建築・設計動向、持続可能な建設に対する規制支援などが挙げられます。

呼吸器疾患の有病率の増加は、今後の乾燥粉末吸入器市場の成長を後押しすると予測されます。呼吸器疾患は、様々な肺疾患を含む呼吸器系に影響を及ぼす幅広い疾患を包含します。ドライパウダー吸入器は、喘息、COPD、嚢胞性線維症などの呼吸器疾患の治療において、薬剤を最も効果的な肺に直接送達することで重要な役割を果たしています。この方法は、呼吸器疾患に対する従来のドラッグデリバリー技術に代わる有望な選択肢となります。例えば、2023年12月に米国医師会の医学雑誌であるJAMA Network Openが発表した研究によると、慢性閉塞性肺疾患（COPD）の世界の負担は、有病率の23％増加を反映して、2050年までに全世界でほぼ6億症例に達すると予測されています。注目すべきは、女性の症例が47.1％増加するのに対し、男性の症例は9.4％しか増加しないと予測されていることです。さらに、これらの症例の大部分は低・中所得地域で発生し、2050年までに有病率は高所得地域の2倍以上になると予測されています。その結果、呼吸器疾患の有病率の増加は、乾燥粉末吸入器市場の拡大を大きく促進することになります。

また、大気汚染レベルの増加も乾燥粉末吸入器市場の成長に寄与すると予測されています。大気中のさまざまな汚染物質の濃度によって測定される大気汚染は、呼吸器系の問題につながるため、ドライパウダー吸入器は、空気中の汚染物質によって悪化する症状を緩和し、呼吸器系の状態を管理する薬剤の送達方法として好まれています。2022年、米国環境保護庁は、米国で大気中に放出された汚染物質の量を約6,600万トンと報告しました。さらに2023年3月、IQAirはイラクが2022年にWHOのPM2.5年間ガイドラインの16倍にあたる80.1μg/m3を記録し、2番目に汚染された国であると報告しました。したがって、大気汚染レベルの上昇は、乾燥粉末吸入器市場の成長を促進すると予想されます。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、コロナ、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界乾燥粉末吸入器PESTEL分析（政治、社会、技術、環境、法的要因、促進要因、抑制要因）
• 最終用途産業の分析
• 世界の乾燥粉末吸入器市場：成長率分析
• 世界の乾燥粉末吸入器市場の実績：規模と成長, 2019-2024
• 世界の乾燥粉末吸入器市場の予測：規模と成長, 2024-2029, 2034F
• 世界乾燥粉末吸入器総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の乾燥粉末吸入器市場：製品別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 単回投与吸入器
• 多用量吸入器
• 世界の乾燥粉末吸入器市場：機能別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 手動吸入器
• デジタル操作式吸入器
• 世界の乾燥粉末吸入器市場：用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 喘息
• 慢性閉塞性肺疾患（COPD）
• 嚢胞性線維症
• その他の用途
• 世界の乾燥粉末吸入器市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院と診療所
• ホームケア設定
• 外来手術センター
• その他のエンドユーザー
• 世界の乾燥粉末吸入器市場、単回投与吸入器の種類別のサブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• カプセル型吸入器
• ディスカスベースの吸入器
• 世界の乾燥粉末吸入器市場、多用量吸入器の種類別のサブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• ブリスターベースの吸入器
• ロタヘラーベースの吸入器

第7章 地域別・国別分析

• 世界の乾燥粉末吸入器市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の乾燥粉末吸入器市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 乾燥粉末吸入器市場：競合情勢
• 乾燥粉末吸入器市場：企業プロファイル
  • Novartis AG Overview, Products and Services, Strategy and Financial Analysis
  • AstraZeneca plc. Overview, Products and Services, Strategy and Financial Analysis
  • GlaxoSmithKline Plc Overview, Products and Services, Strategy and Financial Analysis
  • 3M Company Overview, Products and Services, Strategy and Financial Analysis
  • Boehringer Ingelheim GmbH Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Viatris（Mylan N.V）
• Otsuka Pharmaceutical Co. Ltd
• Sun Pharmaceutical Industries Limited
• Catalent Inc.
• Aptar Group Inc.
• Chiesi Farmaceutici S.p.A.
• Recipharm AB
• Cipla Limited
• Lupin Limited
• Orion Corporation
• OPKO Health
• Zhejiang Hisun Pharmaceutical Co Ltd
• Beximco Pharmaceuticals Ltd
• Sava Healthcare Ltd.
• Hovione

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 乾燥粉末吸入器市場2029：新たな機会を提供する国
• 乾燥粉末吸入器市場2029：新たな機会を提供するセグメント
• 乾燥粉末吸入器市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

A dry powder inhaler (DPI) is a medical device designed for delivering medication in the form of dry powder directly to the lungs. It is primarily used for treating respiratory disorders such as asthma and chronic obstructive pulmonary disease (COPD). To effectively use a DPI, it is crucial for the user to inhale rapidly and deeply, allowing the medication to reach the lungs.

The main types of dry powder inhalers include single-dose inhalers and multi-dose inhalers. Single-dose inhalers are devices that administer medication directly to the lungs in the form of dry powder. These devices can be either manually operated or digitally operated, and they find applications in treating conditions such as asthma, COPD, cystic fibrosis, and others. Various end-users, including hospitals and clinics, homecare settings, and ambulatory surgical centers, utilize these inhalers.

The dry powder inhaler market research report is one of a series of new reports from The Business Research Company that provides dry powder inhaler market statistics, including dry powder inhaler industry global market size, regional shares, competitors with a dry powder inhaler market share, detailed dry powder inhaler market segments, market trends and opportunities, and any further data you may need to thrive in the dry powder inhaler industry. This dry powder inhaler market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The dry powder inhaler market size has grown strongly in recent years. It will grow from $21.25 billion in 2024 to $22.35 billion in 2025 at a compound annual growth rate (CAGR) of 5.2%. The growth in the historic period can be attributed to renewed interest in sustainable building materials, cultural preservation and heritage restoration, rise in green building practices, local sourcing and community involvement, regulatory support and building codes.

The dry powder inhaler market size is expected to see steady growth in the next few years. It will grow to $27.13 billion in 2029 at a compound annual growth rate (CAGR) of 5.0%. The growth in the forecast period can be attributed to continued emphasis on sustainability, global urbanization trends, advancements in manufacturing processes, government incentives and policies, global economic factors. Major trends in the forecast period include increased research and development, renewed interest in traditional building techniques, advancements in material technology, architectural and design trends, regulatory support for sustainable construction.

The increasing prevalence of respiratory diseases is anticipated to boost the growth of the dry powder inhaler market in the future. Respiratory diseases encompass a wide range of disorders affecting the respiratory system, including various lung diseases. Dry powder inhalers play a critical role in treating respiratory conditions such as asthma, COPD, and cystic fibrosis by delivering medication directly to the lungs, where it is most effective. This method serves as a promising alternative to traditional drug delivery techniques for respiratory issues. For example, a study published in December 2023 by JAMA Network Open, a medical journal of the American Medical Association, indicates that the global burden of chronic obstructive pulmonary disease (COPD) is projected to nearly reach 600 million cases worldwide by 2050, reflecting a 23% increase in prevalence. Notably, cases among females are expected to surge by 47.1%, while male cases are projected to rise by only 9.4%. Additionally, the majority of these cases are expected to occur in low- and middle-income regions, where the prevalence is anticipated to be more than double that of high-income areas by 2050. Consequently, the growing prevalence of respiratory diseases will significantly drive the expansion of the dry powder inhaler market.

The increasing levels of air pollution are also anticipated to contribute to the growth of the dry powder inhaler market. Air pollution, measured by the concentration of various pollutants in the atmosphere, leads to respiratory issues, making dry powder inhalers a preferred delivery method for medications that alleviate symptoms and manage respiratory conditions exacerbated by airborne pollutants. In 2022, the United States Environmental Protection Agency reported approximately 66 million tons of pollutants released into the atmosphere in the United States. Additionally, in March 2023, IQAir reported that Iraq was the second most polluted country with 80.1 µg/m3, 16 times higher than the WHO PM2.5 annual guideline in 2022. Therefore, the rising levels of air pollution are expected to drive the growth of the dry powder inhaler market.

Key players in the dry powder inhaler market are focusing on developing innovative products featuring muscarinic antagonists for the treatment of chronic obstructive pulmonary disease (COPD) while also expanding their product portfolios. Muscarinic antagonists are drugs that inhibit the muscarinic acetylcholine receptor, and they are used to manage various conditions, including COPD and organophosphate poisoning. For example, in March 2024, Berry Global, a US-based company recognized for its development and manufacturing of diverse flexible packaging solutions, unveiled its new dry powder inhaler at Pharma Pack. This inhaler is specifically designed to improve drug delivery for respiratory conditions such as COPD and asthma, providing a customizable solution for pharmaceutical companies.

In August 2024, Aptar Pharma, a US-based specialist in drug delivery, acquired the Orbital Dry Powder Inhaler for an undisclosed sum. This acquisition strengthens Aptar's capabilities in respiratory drug delivery, especially for managing conditions such as asthma and chronic obstructive pulmonary disease (COPD). The Orbital Dry Powder Inhaler is noted for its innovative design, which enhances medication delivery. This acquisition aligns with Aptar Pharma's strategy to expand its product offerings and reinforce its position in the respiratory treatment market. The Orbital DPI operates within the pharmaceutical and medical device sectors in India.

Major companies operating in the dry powder inhaler market report are Novartis AG, AstraZeneca plc., GlaxoSmithKline PLC, 3M Company, Boehringer Ingelheim GmbH, Viatris (Mylan N.V), Otsuka Pharmaceutical Co. Ltd., Sun Pharmaceutical Industries Limited, Catalent Inc., Aptar Group Inc., Chiesi Farmaceutici S.p.A., Recipharm AB, Cipla Limited, Lupin Limited, Orion Corporation, OPKO Health, Zhejiang Hisun Pharmaceutical Co Ltd., Beximco Pharmaceuticals Ltd., Sava Healthcare Ltd., Hovione, Elpen S.A., MannKind Corporation, Meda Pharmaceuticals, Presspart Manufacturing Ltd., SMB Laboratories SA, Teva Pharmaceutical Industries Limited, Pharmaxis Ltd., Iconovo AB, SRS Pharmaceuticals Pvt. Ltd.

North America was the largest region in the dry powder inhaler market in 2024. The regions covered in the dry powder inhaler market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the Dry Powder Inhaler market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The dry powder inhaler market consists of sales of dry powder forms, spiriva handihalers, breath-activated inhalers, rotahalers, diskus devices, and twisthaler inhalers. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Dry Powder Inhaler Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on dry powder inhaler market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for dry powder inhaler ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The dry powder inhaler market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product: Single-Dose Inhalers; Multi-Dose Inhalers
• 2) By Function: Manually Operated Inhaler Devices; Digitally Operated Inhaler Devices
• 3) By Application: Asthma; Chronic Obstructive Pulmonary Disease (COPD); Cystic Fibrosis; Other Applications
• 4) By End User: Hospitals And Clinics; Homecare Settings; Ambulatory Surgical Centers; Other End Users
• Subsegments:
• 1) By Single-Dose Inhalers: Capsule-Based Inhalers; Diskus-Based Inhalers
• 2) By Multi-Dose Inhalers: Blister-Based Inhalers; Rotahaler-Based Inhalers
• Companies Mentioned: Novartis AG; AstraZeneca plc.; GlaxoSmithKline Plc; 3M Company; Boehringer Ingelheim GmbH
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Dry Powder Inhaler Market Characteristics

3. Dry Powder Inhaler Market Trends And Strategies

4. Dry Powder Inhaler Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Dry Powder Inhaler Growth Analysis And Strategic Analysis Framework

• 5.1. Global Dry Powder Inhaler PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Dry Powder Inhaler Market Growth Rate Analysis
• 5.4. Global Dry Powder Inhaler Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Dry Powder Inhaler Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Dry Powder Inhaler Total Addressable Market (TAM)

6. Dry Powder Inhaler Market Segmentation

• 6.1. Global Dry Powder Inhaler Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Single-Dose Inhalers
• Multi-Dose Inhalers
• 6.2. Global Dry Powder Inhaler Market, Segmentation By Function, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Manually Operated Inhaler Devices
• Digitally Operated Inhaler Devices
• 6.3. Global Dry Powder Inhaler Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Asthma
• Chronic Obstructive Pulmonary Disease (COPD)
• Cystic Fibrosis
• Other Applications
• 6.4. Global Dry Powder Inhaler Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals And Clinics
• Homecare Settings
• Ambulatory Surgical Centers
• Other End Users
• 6.5. Global Dry Powder Inhaler Market, Sub-Segmentation Of Single-Dose Inhalers, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Capsule-Based Inhalers
• Diskus-Based Inhalers
• 6.6. Global Dry Powder Inhaler Market, Sub-Segmentation Of Multi-Dose Inhalers, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Blister-Based Inhalers
• Rotahaler-Based Inhalers

7. Dry Powder Inhaler Market Regional And Country Analysis

• 7.1. Global Dry Powder Inhaler Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Dry Powder Inhaler Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Dry Powder Inhaler Market

• 8.1. Asia-Pacific Dry Powder Inhaler Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Dry Powder Inhaler Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Dry Powder Inhaler Market, Segmentation By Function, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Dry Powder Inhaler Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Dry Powder Inhaler Market

• 9.1. China Dry Powder Inhaler Market Overview
• 9.2. China Dry Powder Inhaler Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Dry Powder Inhaler Market, Segmentation By Function, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Dry Powder Inhaler Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Dry Powder Inhaler Market

• 10.1. India Dry Powder Inhaler Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Dry Powder Inhaler Market, Segmentation By Function, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Dry Powder Inhaler Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Dry Powder Inhaler Market

• 11.1. Japan Dry Powder Inhaler Market Overview
• 11.2. Japan Dry Powder Inhaler Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Dry Powder Inhaler Market, Segmentation By Function, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Dry Powder Inhaler Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Dry Powder Inhaler Market

• 12.1. Australia Dry Powder Inhaler Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Dry Powder Inhaler Market, Segmentation By Function, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Dry Powder Inhaler Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Dry Powder Inhaler Market

• 13.1. Indonesia Dry Powder Inhaler Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Dry Powder Inhaler Market, Segmentation By Function, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Dry Powder Inhaler Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Dry Powder Inhaler Market

• 14.1. South Korea Dry Powder Inhaler Market Overview
• 14.2. South Korea Dry Powder Inhaler Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Dry Powder Inhaler Market, Segmentation By Function, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Dry Powder Inhaler Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Dry Powder Inhaler Market

• 15.1. Western Europe Dry Powder Inhaler Market Overview
• 15.2. Western Europe Dry Powder Inhaler Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Dry Powder Inhaler Market, Segmentation By Function, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Dry Powder Inhaler Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Dry Powder Inhaler Market

• 16.1. UK Dry Powder Inhaler Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Dry Powder Inhaler Market, Segmentation By Function, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Dry Powder Inhaler Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Dry Powder Inhaler Market

• 17.1. Germany Dry Powder Inhaler Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Dry Powder Inhaler Market, Segmentation By Function, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Dry Powder Inhaler Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Dry Powder Inhaler Market

• 18.1. France Dry Powder Inhaler Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Dry Powder Inhaler Market, Segmentation By Function, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Dry Powder Inhaler Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Dry Powder Inhaler Market

• 19.1. Italy Dry Powder Inhaler Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Dry Powder Inhaler Market, Segmentation By Function, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Dry Powder Inhaler Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Dry Powder Inhaler Market

• 20.1. Spain Dry Powder Inhaler Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Dry Powder Inhaler Market, Segmentation By Function, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Dry Powder Inhaler Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Dry Powder Inhaler Market

• 21.1. Eastern Europe Dry Powder Inhaler Market Overview
• 21.2. Eastern Europe Dry Powder Inhaler Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Dry Powder Inhaler Market, Segmentation By Function, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Dry Powder Inhaler Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Dry Powder Inhaler Market

• 22.1. Russia Dry Powder Inhaler Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Dry Powder Inhaler Market, Segmentation By Function, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Dry Powder Inhaler Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Dry Powder Inhaler Market

• 23.1. North America Dry Powder Inhaler Market Overview
• 23.2. North America Dry Powder Inhaler Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Dry Powder Inhaler Market, Segmentation By Function, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Dry Powder Inhaler Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Dry Powder Inhaler Market

• 24.1. USA Dry Powder Inhaler Market Overview
• 24.2. USA Dry Powder Inhaler Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Dry Powder Inhaler Market, Segmentation By Function, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Dry Powder Inhaler Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Dry Powder Inhaler Market

• 25.1. Canada Dry Powder Inhaler Market Overview
• 25.2. Canada Dry Powder Inhaler Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Dry Powder Inhaler Market, Segmentation By Function, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Dry Powder Inhaler Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Dry Powder Inhaler Market

• 26.1. South America Dry Powder Inhaler Market Overview
• 26.2. South America Dry Powder Inhaler Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Dry Powder Inhaler Market, Segmentation By Function, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Dry Powder Inhaler Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Dry Powder Inhaler Market

• 27.1. Brazil Dry Powder Inhaler Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Dry Powder Inhaler Market, Segmentation By Function, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Dry Powder Inhaler Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Dry Powder Inhaler Market

• 28.1. Middle East Dry Powder Inhaler Market Overview
• 28.2. Middle East Dry Powder Inhaler Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Dry Powder Inhaler Market, Segmentation By Function, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Dry Powder Inhaler Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Dry Powder Inhaler Market

• 29.1. Africa Dry Powder Inhaler Market Overview
• 29.2. Africa Dry Powder Inhaler Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Dry Powder Inhaler Market, Segmentation By Function, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Dry Powder Inhaler Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Dry Powder Inhaler Market Competitive Landscape And Company Profiles

• 30.1. Dry Powder Inhaler Market Competitive Landscape
• 30.2. Dry Powder Inhaler Market Company Profiles
  • 30.2.1. Novartis AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. AstraZeneca plc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. GlaxoSmithKline Plc Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. 3M Company Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Boehringer Ingelheim GmbH Overview, Products and Services, Strategy and Financial Analysis

31. Dry Powder Inhaler Market Other Major And Innovative Companies

• 31.1. Viatris (Mylan N.V)
• 31.2. Otsuka Pharmaceutical Co. Ltd
• 31.3. Sun Pharmaceutical Industries Limited
• 31.4. Catalent Inc.
• 31.5. Aptar Group Inc.
• 31.6. Chiesi Farmaceutici S.p.A.
• 31.7. Recipharm AB
• 31.8. Cipla Limited
• 31.9. Lupin Limited
• 31.10. Orion Corporation
• 31.11. OPKO Health
• 31.12. Zhejiang Hisun Pharmaceutical Co Ltd
• 31.13. Beximco Pharmaceuticals Ltd
• 31.14. Sava Healthcare Ltd.
• 31.15. Hovione

32. Global Dry Powder Inhaler Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Dry Powder Inhaler Market

34. Recent Developments In The Dry Powder Inhaler Market

35. Dry Powder Inhaler Market High Potential Countries, Segments and Strategies

• 35.1 Dry Powder Inhaler Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Dry Powder Inhaler Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Dry Powder Inhaler Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer